Immunogen (IMGN) Misses Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q3 EPS of ($0.37), $0.05 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $19.7 million versus the consensus estimate of $23.02 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- First Advantage Corporation (FA) Tops Q2 EPS by 6c ; Offers Guidance
- Enerflex (EFXT) Misses Q2 EPS by 6c
- Tennant Co. (TNC) Misses Q2 EPS by 53c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
